Skip to main content

Advertisement

SpringerLink
Log in

Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification

  • Review
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Although placebo response rates in clinical trials for functional dyspepsia (FD) are more than 30%, a recent meta-analysis based on randomized controlled trials (RCTs) showed that antisecretory drugs were more or less superior to placebos. On the other hand, large-scale RCTs on the efficacy of treatment with prokinetics on FD are still needed. Indications for antibiotic eradication therapy for Helicobacter pylori-positive FD are still controversial, but there seems to be a small but significant therapeutic gain achieved with H. pylori eradication. Since preprandial and postprandial symptomatic disturbances are very important targets for FD treatment, ghrelin, a novel appetite-promoting gastrointestinal peptide that also promotes gastric motility or basal acid secretion can be expected to be a therapeutic target. In the recently published Rome III classification, FD is redefined for patients with symptoms thought to originate from the gastroduodenal region, specifically epigastric pain or burning, postprandial fullness, or early satiation, and it is divided into the subcategories postprandial distress syndrome and epigastric pain syndrome. These new criteria are of value in clinical practice, for epidemiological, pathophysiological, and clinical research, and for the development of new therapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DA Drossman (1999) ArticleTitleThe functional gastrointestinal disorders and the Rome II process Gut 45 IssueIDSuppl 2 II1–5 Occurrence Handle10457038 Occurrence Handle10.1136/gut.45.2008.ii1

    Article  PubMed  Google Scholar 

  2. DA Drossman (2006) ArticleTitleThe functional gastrointestinal disorders and the Rome III process Gastroenterology 130 1377–90 Occurrence Handle16678553 Occurrence Handle10.1053/j.gastro.2006.03.008

    Article  PubMed  Google Scholar 

  3. P Bytzer NJ Talley (2001) ArticleTitleDyspepsia Ann Intern Med 134 815–22 Occurrence Handle11346316 Occurrence Handle1:STN:280:DC%2BD3M3lsFWgtw%3D%3D

    PubMed  CAS  Google Scholar 

  4. NJ Talley N Vakil (2005) ArticleTitleGuidelines for the management of dyspepsia Am J Gastroenterol 100 2324–37 Occurrence Handle16181387 Occurrence Handle10.1111/j.1572-0241.2005.00225.x

    Article  PubMed  Google Scholar 

  5. J Tack NJ Talley M Camilleri G Holtmann P Hu JR Malagelada et al. (2006) ArticleTitleFunctional gastroduodenal disorders Gastroenterology 130 1466–79 Occurrence Handle16678560 Occurrence Handle10.1053/j.gastro.2005.11.059

    Article  PubMed  Google Scholar 

  6. NJ Talley V Stanghellini RC Heading KL Koch JR Malagelada GN Tytgat (1999) ArticleTitleFunctional gastroduodenal disorders Gut 45 IssueIDSuppl II 37–42

    Google Scholar 

  7. F Mearin M Cucala F Aspiroz JF Malagelada (1991) ArticleTitleThe origin of symptoms of the brain–gut axis in functional dyspepsia Gastroenterology 101 999–1006 Occurrence Handle1889724 Occurrence Handle1:STN:280:DyaK3MzmsFajtQ%3D%3D

    PubMed  CAS  Google Scholar 

  8. DA Peura TO Kovacs DC Metz N Siepman BL Pilmer NJ Talley (2004) ArticleTitleLansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials Am J Med 116 740–8 Occurrence Handle15144910 Occurrence Handle1:CAS:528:DC%2BD2cXktVCku78%3D Occurrence Handle10.1016/j.amjmed.2004.01.008

    Article  PubMed  CAS  Google Scholar 

  9. J Tack P Caenepeel J Arts KJ Lee D Sifrim J Janssens (2005) ArticleTitlePrevalence of acid reflux in functional dyspepsia and its association with symptom profile Gut 54 1370–6 Occurrence Handle15972301 Occurrence Handle1:STN:280:DC%2BD2MvptF2qug%3D%3D Occurrence Handle10.1136/gut.2004.053355

    Article  PubMed  CAS  Google Scholar 

  10. R Carlsson J Dent E Bolling-Sternevald F Johnsson O Junghard K Lauritsen et al. (1998) ArticleTitleThe usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease Scand J Gastroenterol 33 1023–9 Occurrence Handle9829354 Occurrence Handle1:STN:280:DyaK1M%2FksVyiuw%3D%3D Occurrence Handle10.1080/003655298750026697

    Article  PubMed  CAS  Google Scholar 

  11. P Moayyedi BC Delaney N Vakil D Forman NJ Talley (2004) ArticleTitleThe efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis Gastroenterology 127 1329–37 Occurrence Handle15521002 Occurrence Handle10.1053/j.gastro.2004.08.026

    Article  PubMed  Google Scholar 

  12. AB Thomson AN Barkun D Armstrong N Chiba RJ White S Daniels et al. (2003) ArticleTitleThe prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment–Prompt Endoscopy (CADET-PE) study Aliment Pharmacol Ther 17 1481–91 Occurrence Handle12823150 Occurrence Handle1:STN:280:DC%2BD3s3psFOnug%3D%3D Occurrence Handle10.1046/j.1365-2036.2003.01646.x

    Article  PubMed  CAS  Google Scholar 

  13. WG Thompson (2000) ArticleTitlePlacebos: a review of the placebo response Am J Gastroenterol 95 1637–43 Occurrence Handle10925962 Occurrence Handle1:STN:280:DC%2BD3cvgvVWnsQ%3D%3D Occurrence Handle10.1111/j.1572-0241.2000.02179.x

    Article  PubMed  CAS  Google Scholar 

  14. NJ Talley GR Locke BD Lahr AR Zinsmeister M Cohard-Radice TV D'Elia et al. (2006) ArticleTitlePredictors of the placebo response in functional dyspepsia Aliment Pharmacol Ther 23 923–36 Occurrence Handle16573795 Occurrence Handle1:STN:280:DC%2BD287nvFKktQ%3D%3D Occurrence Handle10.1111/j.1365-2036.2006.02845.x

    Article  PubMed  CAS  Google Scholar 

  15. JS Finney N Kinnersley M Hughes CG O'Bryan-Tear J Lothian (1998) ArticleTitleMeta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia J Clin Gastroenterol 26 312–20 Occurrence Handle9649020 Occurrence Handle1:STN:280:DyaK1czhtFemtg%3D%3D Occurrence Handle10.1097/00004836-199806000-00022

    Article  PubMed  CAS  Google Scholar 

  16. HD Allescher A Bockenhoff G Knapp M Wienbeck J Hartung (2001) ArticleTitleTreatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies Scand J Gastroenterol 36 934–41 Occurrence Handle11521983 Occurrence Handle1:CAS:528:DC%2BD3MXmslWgur4%3D Occurrence Handle10.1080/003655201750305440

    Article  PubMed  CAS  Google Scholar 

  17. HA Redstone N Barrowman SJ Veldhuyzen Van Zanten (2001) ArticleTitleH2-receptor antagonists in the treatment of functional (non-ulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials Aliment Pharmacol Ther 15 1291–9 Occurrence Handle11552898 Occurrence Handle1:CAS:528:DC%2BD3MXnt1Gjs7g%3D Occurrence Handle10.1046/j.1365-2036.2001.01044.x

    Article  PubMed  CAS  Google Scholar 

  18. NS Abraham P Moayyedi B Daniels SJ Veldhuyzen Van Zanten (2004) ArticleTitleSystematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia Aliment Pharmacol Ther 19 631–41 Occurrence Handle15023165 Occurrence Handle1:STN:280:DC%2BD2c7jtVOmtQ%3D%3D Occurrence Handle10.1111/j.1365-2036.2004.01878.x

    Article  PubMed  CAS  Google Scholar 

  19. P Moayyedi S Soo J Deeks B Delaney M Innes D Forman (2004) ArticleTitlePharmacological interventions for non-ulcer dyspepsia Cochrane Database Syst Rev 4 CD001960 Occurrence Handle15495023

    PubMed  Google Scholar 

  20. WM Wong BC Wong WK Hung YK Yee AW Yip ML Szeto et al. (2002) ArticleTitleDouble blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients Gut 51 502–6 Occurrence Handle12235071 Occurrence Handle1:CAS:528:DC%2BD3sXhslWmtrk%3D Occurrence Handle10.1136/gut.51.4.502

    Article  PubMed  CAS  Google Scholar 

  21. E Bolling-Sternevald K Lauritsen C Aalykke T Havelund T Knudsen P Unge et al. (2002) ArticleTitleEffect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial Scand J Gastroenterol 37 1395–402 Occurrence Handle12523588 Occurrence Handle1:CAS:528:DC%2BD3sXht1Sit7o%3D Occurrence Handle10.1080/003655202762671260

    Article  PubMed  CAS  Google Scholar 

  22. E Bolling-Sternevald K Lauritsen NJ Talley O Junghard H Glise (2003) ArticleTitleIs it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Aliment Pharmacol Ther 18 117–24 Occurrence Handle12848633 Occurrence Handle1:CAS:528:DC%2BD3sXmvFWgsLk%3D Occurrence Handle10.1046/j.1365-2036.2003.01651.x

    Article  PubMed  CAS  Google Scholar 

  23. RH Jones G Baxter (1997) ArticleTitleLansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice Aliment Pharmacol Ther 11 541–6 Occurrence Handle9218080 Occurrence Handle1:CAS:528:DyaK2sXks1egt74%3D Occurrence Handle10.1046/j.1365-2036.1997.00179.x

    Article  PubMed  CAS  Google Scholar 

  24. H Seno H Nakase T Chiba (2005) ArticleTitleUsefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies Aliment Pharmacol Ther 21 IssueIDSuppl 2 32–6 Occurrence Handle15943844 Occurrence Handle1:CAS:528:DC%2BD2MXlvFShtbw%3D Occurrence Handle10.1111/j.1365-2036.2005.02471.x

    Article  PubMed  CAS  Google Scholar 

  25. M Kato M Watanabe S Konishi M Kudo J Konno T Meguro (2005) ArticleTitleRandomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia Aliment Pharmacol Ther 21 IssueIDSuppl 2 27–31 Occurrence Handle15943843 Occurrence Handle1:CAS:528:DC%2BD2MXlvFShtb8%3D Occurrence Handle10.1111/j.1365-2036.2005.02470.x

    Article  PubMed  CAS  Google Scholar 

  26. G Holtmann SU Kutscher S Haag M Langkafel G Heuft J Neufang-Hueber et al. (2004) ArticleTitleClinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia; a randomized, double-blind placebo-controlled crossover study Dig Dis Sci 49 672–9 Occurrence Handle15185877 Occurrence Handle10.1023/B:DDAS.0000026317.00071.75

    Article  PubMed  Google Scholar 

  27. P Moayyedi S Soo J Deeks B Delaney M Innes D Forman (2003) ArticleTitlePharmacological interventions for non-ulcer dyspepsia Cochrane Database Syst Rev 1 CD001960 Occurrence Handle12535421

    PubMed  Google Scholar 

  28. NJ Talley V Meineche-Schmidt P Pare M Duckworth P Raisanen A Pap et al. (1998) ArticleTitleEfficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies) Aliment Pharmacol Ther 12 1055–65 Occurrence Handle9845395 Occurrence Handle1:CAS:528:DyaK1cXotVeruro%3D Occurrence Handle10.1046/j.1365-2036.1998.00410.x

    Article  PubMed  CAS  Google Scholar 

  29. AL Blum R Arnold M Stolte M Fischer HR Koelz (2000) ArticleTitleShort course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group Gut 47 473–80 Occurrence Handle10986206 Occurrence Handle1:CAS:528:DC%2BD3cXnsVCrur0%3D Occurrence Handle10.1136/gut.47.4.473

    Article  PubMed  CAS  Google Scholar 

  30. M Asaka K Satoh K Sugano T Sugiyama S Takahashi Y Fukuda et al. (2001) ArticleTitleGuidelines in the management of Helicobacter pylori infection in Japan Helicobacter 6 177–86 Occurrence Handle11683920 Occurrence Handle1:STN:280:DC%2BD3MnjsFalsA%3D%3D Occurrence Handle10.1046/j.1523-5378.2001.00027.x

    Article  PubMed  CAS  Google Scholar 

  31. K McColl L Murray E El-Omar A Dickson A El-Nujumi A Wirz et al. (1998) ArticleTitleSymptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia N Engl J Med 339 1869–74 Occurrence Handle9862941 Occurrence Handle1:STN:280:DyaK1M%2FmslWmsg%3D%3D Occurrence Handle10.1056/NEJM199812243392601

    Article  PubMed  CAS  Google Scholar 

  32. AL Blum NJ Talley C O'Morain SV van Zanten J Labenz M Stolte et al. (1998) ArticleTitleLack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group N Engl J Med 339 1875–81 Occurrence Handle9862942 Occurrence Handle1:STN:280:DyaK1M%2FmslWmsw%3D%3D Occurrence Handle10.1056/NEJM199812243392602

    Article  PubMed  CAS  Google Scholar 

  33. P Moayyedi S Soo J Deeks B Delaney A Harris M Innes et al. (2003) ArticleTitleEradication of Helicobacter pylori for non-ulcer dyspepsia Cochrane Database Syst Rev 1 CD002096 Occurrence Handle12535429

    PubMed  Google Scholar 

  34. L Laine P Schoenfeld MB Fennerty (2001) ArticleTitleTherapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials Ann Intern Med 134 361–9 Occurrence Handle11242496 Occurrence Handle1:STN:280:DC%2BD3M7lt1ehsQ%3D%3D

    PubMed  CAS  Google Scholar 

  35. NJ Talley N Vakil ED Ballard Suffix2nd MB Fennerty (1999) ArticleTitleAbsence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia N Engl J Med 341 1106–11 Occurrence Handle10511608 Occurrence Handle1:STN:280:DyaK1Mvis1Grtg%3D%3D Occurrence Handle10.1056/NEJM199910073411502

    Article  PubMed  CAS  Google Scholar 

  36. P Moayyedi R Feltbower J Brown S Mason J Mason J Nathan et al. (2000) ArticleTitleEffect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group Lancet 355 1665–9 Occurrence Handle10905240 Occurrence Handle1:STN:280:DC%2BD3czmtFWktw%3D%3D Occurrence Handle10.1016/S0140-6736(00)02236-4

    Article  PubMed  CAS  Google Scholar 

  37. GK Dhali PK Garg MP Sharma (1999) ArticleTitleRole of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians J Gastroenterol Hepatol 14 523–8 Occurrence Handle10385059 Occurrence Handle1:CAS:528:DyaK1MXktVeitr0%3D Occurrence Handle10.1046/j.1440-1746.1999.01909.x

    Article  PubMed  CAS  Google Scholar 

  38. RL Jaakkimainen E Boyle F Tudiver (1999) ArticleTitleIs Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis BMJ 319 1040–4 Occurrence Handle10521198 Occurrence Handle1:STN:280:DyaK1MvltFSjsA%3D%3D

    PubMed  CAS  Google Scholar 

  39. P Moayyedi S Soo J Deeks D Forman J Mason M Innes B Delaney (2000) ArticleTitleSystematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group BMJ 321 659–64 Occurrence Handle10987767 Occurrence Handle1:STN:280:DC%2BD3M%2FhvFWrtQ%3D%3D Occurrence Handle10.1136/bmj.321.7262.659

    Article  PubMed  CAS  Google Scholar 

  40. P Moayyedi S Soo J Deeks B Delaney A Harris M Innes et al. (2006) ArticleTitleEradication of Helicobacter pylori for non-ulcer dyspepsia Cochrane Database Syst Rev 2 CD002096 Occurrence Handle16625554

    PubMed  Google Scholar 

  41. D McNamara M Buckley J Gilvarry C O'Morain (2002) ArticleTitleDoes Helicobacter pylori eradication affect symptoms in non-ulcer dyspepsia: a 5-year follow-up study Helicobacter 7 317–21 Occurrence Handle12390212 Occurrence Handle1:STN:280:DC%2BD38njt1Kitg%3D%3D Occurrence Handle10.1046/j.1523-5378.2002.00104.x

    Article  PubMed  CAS  Google Scholar 

  42. PI Hsu KH Lai GH Lo HH Tseng CC Lo HC Chen et al. (2002) ArticleTitleRisk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients Gut 51 15–20 Occurrence Handle12077085 Occurrence Handle10.1136/gut.51.1.15

    Article  PubMed  Google Scholar 

  43. H Suzuki T Masaoka G Sakai H Ishii T Hibi (2005) ArticleTitleImprovement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy J Gastroenterol Hepatol 20 1652–60 Occurrence Handle16246181 Occurrence Handle10.1111/j.1440-1746.2005.04039.x

    Article  PubMed  Google Scholar 

  44. Nishizawa T, Suzuki H, Nomoto Y, Masaoka T, Hosoda H, Mori M, et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther Symp Ser 2006;2:(in press)

  45. J Svedlund I Sjodin G Dotevall (1988) ArticleTitleGSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease Dig Dis Sci 33 129–34 Occurrence Handle3123181 Occurrence Handle1:STN:280:DyaL1c7htV2htg%3D%3D Occurrence Handle10.1007/BF01535722

    Article  PubMed  CAS  Google Scholar 

  46. NJ Talley (2001) ArticleTitleTherapeutic options in nonulcer dyspepsia J Clin Gastroenterol 32 286–93 Occurrence Handle11276271 Occurrence Handle1:STN:280:DC%2BD3M7oslWrtA%3D%3D Occurrence Handle10.1097/00004836-200104000-00004

    Article  PubMed  CAS  Google Scholar 

  47. NJ Talley M Verlinden M Jones (2001) ArticleTitleCan symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 96 1422–8 Occurrence Handle11374677 Occurrence Handle1:STN:280:DC%2BD3M3ptFyrsg%3D%3D Occurrence Handle10.1111/j.1572-0241.2001.03683.x

    Article  PubMed  CAS  Google Scholar 

  48. R Dhir JE Richter (2004) ArticleTitleErythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis J Clin Gastroenterol 38 237–42 Occurrence Handle15128069 Occurrence Handle1:CAS:528:DC%2BD2cXktlKhsr4%3D Occurrence Handle10.1097/00004836-200403000-00008

    Article  PubMed  CAS  Google Scholar 

  49. J Tack R Bisschops B DeMarchi (2001) ArticleTitleCauses and treatment of functional dyspepsia Curr Gastroenterol Rep 3 503–8 Occurrence Handle11696288 Occurrence Handle1:STN:280:DC%2BD3MnksVWjsg%3D%3D

    PubMed  CAS  Google Scholar 

  50. BI Hallerback G Bommelaer E Bredberg M Campbell M Hellblom K Lauritsen et al. (2002) ArticleTitleDose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study Aliment Pharmacol Ther 16 959–67 Occurrence Handle11966505 Occurrence Handle1:CAS:528:DC%2BD38Xkt1Gktr4%3D Occurrence Handle10.1046/j.1365-2036.2002.01236.x

    Article  PubMed  CAS  Google Scholar 

  51. M Otaka M Jin M Odashima T Matsuhashi I Wada Y Horikawa et al. (2005) ArticleTitleNew strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline Aliment Pharmacol Ther 21 IssueIDSuppl 2 42–6 Occurrence Handle15943846 Occurrence Handle1:CAS:528:DC%2BD2MXlvFShtbo%3D Occurrence Handle10.1111/j.1365-2036.2005.02473.x

    Article  PubMed  CAS  Google Scholar 

  52. Y Kinoshita T Hashimoto A Kawamura M Yuki K Amano H Sato et al. (2005) ArticleTitleEffects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia Aliment Pharmacol Ther 21 IssueIDSuppl 2 37–41 Occurrence Handle15943845 Occurrence Handle1:CAS:528:DC%2BD2MXlvFShtb0%3D Occurrence Handle10.1111/j.1365-2036.2005.02472.x

    Article  PubMed  CAS  Google Scholar 

  53. Hongo M. Initial approach and pharmacotherapy for functional dyspepsia—a large clinical trial in Japan. Gastroenterology 2006;130(4)(Suppl 2):A-506 (abstract)

    Google Scholar 

  54. LE Troncon RJ Bennett NK Ahluwalia DG Thompson (1994) ArticleTitleAbnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients Gut 35 327–32 Occurrence Handle8150341 Occurrence Handle1:STN:280:DyaK2c3gtVKmtQ%3D%3D

    PubMed  CAS  Google Scholar 

  55. LE Troncon DG Thompson NK Ahluwalia J Barlow L Heggie (1995) ArticleTitleRelations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy Gut 37 17–22 Occurrence Handle7672673 Occurrence Handle1:STN:280:DyaK2Mvgt1yjsw%3D%3D

    PubMed  CAS  Google Scholar 

  56. J Tack H Piessevaux B Coulie P Caenepeel J Janssens (1998) ArticleTitleRole of impaired gastric accommodation to a meal in functional dyspepsia Gastroenterology 115 1346–52 Occurrence Handle9834261 Occurrence Handle1:STN:280:DyaK1M%2FlsFGktw%3D%3D Occurrence Handle10.1016/S0016-5085(98)70012-5

    Article  PubMed  CAS  Google Scholar 

  57. T Hayakawa T Arakawa Y Kase S Akiyama A Ishige S Takeda et al. (1999) ArticleTitleLiu-jun-zi-tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs Drugs Exp Clin Res 25 211–8 Occurrence Handle10568209 Occurrence Handle1:CAS:528:DyaK1MXns1Gjsbg%3D

    PubMed  CAS  Google Scholar 

  58. T Kido Y Nakai Y Kase I Sakakibara M Nomura S Takeda et al. (2005) ArticleTitleEffects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-l-arginine J Pharmacol Sci 98 161–7 Occurrence Handle15937402 Occurrence Handle1:CAS:528:DC%2BD2MXlslCrtrw%3D Occurrence Handle10.1254/jphs.FPJ04056X

    Article  PubMed  CAS  Google Scholar 

  59. J Tack R Vos J Janssens J Salter S Jauffret G Vandeplassche (2003) ArticleTitleInfluence of tegaserod on proximal gastric tone and on the perception of gastric distension Aliment Pharmacol Ther 18 1031–7 Occurrence Handle14616170 Occurrence Handle1:CAS:528:DC%2BD2cXptler Occurrence Handle10.1046/j.1365-2036.2003.01775.x

    Article  PubMed  CAS  Google Scholar 

  60. G Riezzo C Clemente S Leo F Russo (2005) ArticleTitleThe role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptoms J Gastroenterol 40 1107–15 Occurrence Handle16378174 Occurrence Handle1:CAS:528:DC%2BD2MXhtlGhsLvM Occurrence Handle10.1007/s00535-005-1708-7

    Article  PubMed  CAS  Google Scholar 

  61. L Tanum UF Malt (1996) ArticleTitleA new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin Scand J Gastroenterol 31 318–25 Occurrence Handle8726297 Occurrence Handle1:CAS:528:DyaK28XislKmtr8%3D

    PubMed  CAS  Google Scholar 

  62. H Mertz R Fass A Kodner F Yan-Go S Fullerton EA Mayer (1998) ArticleTitleEffect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia Am J Gastroenterol 93 160–5 Occurrence Handle9468233 Occurrence Handle1:CAS:528:DyaK1cXmt1GrsrY%3D Occurrence Handle10.1111/j.1572-0241.1998.00160.x

    Article  PubMed  CAS  Google Scholar 

  63. EL Calvert LA Houghton P Cooper J Morris PJ Whorwell (2002) ArticleTitleLong-term improvement in functional dyspepsia using hypnotherapy Gastroenterology 123 1778–85 Occurrence Handle12454833 Occurrence Handle10.1053/gast.2002.37071

    Article  PubMed  Google Scholar 

  64. S Soo P Moayyedi J Deeks B Delaney M Lewis D Forman (2005) ArticleTitlePsychological interventions for non-ulcer dyspepsia Cochrane Database Syst Rev 2 CD002301 Occurrence Handle15846636

    PubMed  Google Scholar 

  65. M Hojo H Miwa T Yokoyama T Ohkusa A Nagahara M Kawabe et al. (2005) ArticleTitleTreatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review J Gastroenterol 40 1036–42 Occurrence Handle16322947 Occurrence Handle1:CAS:528:DC%2BD2MXht1OqsLnM Occurrence Handle10.1007/s00535-005-1687-8

    Article  PubMed  CAS  Google Scholar 

  66. G McHardy M Atik L Balart D Sekinger R McHardy H Cradic et al. (1964) ArticleTitleAn evaluation of gastric hypothermia Am J Dig Dis 35 717–25 Occurrence Handle14215824 Occurrence Handle1:STN:280:CCqD38%2FitFM%3D Occurrence Handle10.1007/BF02237731

    Article  PubMed  CAS  Google Scholar 

  67. EM Deutsch (1971) ArticleTitleRelief of anxiety and related emotions in patients with gastrointestinal disorders. A double-blind controlled study Am J Dig Dis 16 1091–4 Occurrence Handle4944409 Occurrence Handle1:STN:280:DyaE38%2FoslCksA%3D%3D Occurrence Handle10.1007/BF02235166

    Article  PubMed  CAS  Google Scholar 

  68. K Mine F Kanazawa M Hosoi N Kinukawa C Kubo (1998) ArticleTitleTreating nonulcer dyspepsia considering both functional disorders of the digestive system and psychiatric conditions Dig Dis Sci 43 1241–7 Occurrence Handle9635614 Occurrence Handle1:STN:280:DyaK1c3pslGgtQ%3D%3D Occurrence Handle10.1023/A:1018855724017

    Article  PubMed  CAS  Google Scholar 

  69. M Kojima H Hosoda Y Date M Nakazato H Matsuo K Kangawa (1999) ArticleTitleGhrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 656–60 Occurrence Handle10604470 Occurrence Handle1:CAS:528:DC%2BD3cXjs1Ki Occurrence Handle10.1038/45230

    Article  PubMed  CAS  Google Scholar 

  70. Y Masuda T Tanaka N Inomata N Ohnuma S Tanaka Z Itoh et al. (2000) ArticleTitleGhrelin stimulates gastric acid secretion and motility in rats Biochem Biophys Res Commun 276 905–8 Occurrence Handle11027567 Occurrence Handle1:CAS:528:DC%2BD3cXntFOqsrg%3D Occurrence Handle10.1006/bbrc.2000.3568

    Article  PubMed  CAS  Google Scholar 

  71. Mori M, Suzuki H, Masaoka T, Imaeda H, Nomoto Y, Hosoda H, et al. Intravenous ghrelin administration enhances gastric acid secretion—evaluation using wireless pH capsule. Aliment Pharmacol Ther Symp Ser 2006;2:(in press)

  72. J Tack I Depoortere R Bisschops C Delporte B Coulie A Meulemans et al. (2006) ArticleTitleInfluence of ghrelin on interdigestive gastrointestinal motility in humans Gut 55 327–33 Occurrence Handle16216827 Occurrence Handle1:CAS:528:DC%2BD28Xis1SjsLY%3D Occurrence Handle10.1136/gut.2004.060426

    Article  PubMed  CAS  Google Scholar 

  73. H Suzuki T Masaoka H Hosoda T Ota Y Minegishi S Nomura et al. (2004) ArticleTitleHelicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils Gut 53 187–94 Occurrence Handle14724148 Occurrence Handle1:CAS:528:DC%2BD2cXhs1Ght70%3D Occurrence Handle10.1136/gut.2003.021568

    Article  PubMed  CAS  Google Scholar 

  74. Y Abiko H Suzuki T Masaoka S Nomura K Kurabayashi H Hosoda et al. (2005) ArticleTitleEnhanced plasma ghrelin levels in Helicobacter pylori-colonized, interleukin-1-receptor type 1-homozygous knockout (IL-1R1−/−) mice World J Gastroenterol 11 4148–53 Occurrence Handle16015681 Occurrence Handle1:CAS:528:DC%2BD2MXpvVWitLg%3D

    PubMed  CAS  Google Scholar 

  75. T Nishizawa H Suzuki T Masaoka Y Nomoto Y Minegishi H Hosoda et al. (2006) ArticleTitleEmotional stress enhanced ghrelin secretion from the stomach J Clin Biochem Nutr 38 33–7 Occurrence Handle1:CAS:528:DC%2BD28XjvVWqsLk%3D

    CAS  Google Scholar 

  76. H Suzuki T Masaoka H Hosoda S Nomura T Ohara K Kangawa et al. (2004) ArticleTitlePlasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio—a possible novel and non-invasive marker for gastric atrophy Hepatogastroenterology 51 1249–54 Occurrence Handle15362725 Occurrence Handle1:CAS:528:DC%2BD2cXmvVGiu78%3D

    PubMed  CAS  Google Scholar 

  77. T Masaoka H Suzuki H Imaeda H Hosoda T Ohara T Morishita et al. (2005) ArticleTitleLong-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication Hepatogastroenterology 52 1–4 Occurrence Handle15782980

    PubMed  Google Scholar 

  78. S Fukuhara H Suzuki T Masaoka M Arakawa H Hosoda Y Minegishi et al. (2005) ArticleTitleEnhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers Am J Physiol Gastrointest Liver Physiol 289 G138–45 Occurrence Handle15778430 Occurrence Handle1:CAS:528:DC%2BD2MXmvVeqs78%3D Occurrence Handle10.1152/ajpgi.00298.2004

    Article  PubMed  CAS  Google Scholar 

  79. Suzuki H, Masaoka T, Nomoto Y, Hosoda H, Mori M, Nishizawa T, et al. Increased levels of plasma ghrelin in peptic ulcer disease. Aliment Pharmacol Ther Symp Ser 2006;2:(in press)

  80. T Shinomiya M Fukunaga T Akamizu T Irako M Yokode K Kangawa et al. (2005) ArticleTitlePlasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients Scand J Gastroenterol 40 648–53 Occurrence Handle16036524 Occurrence Handle1:CAS:528:DC%2BD2MXksVejs7Y%3D

    PubMed  CAS  Google Scholar 

  81. PG Farup PO Vandvik L Aabakken (2005) ArticleTitleHow useful are the Rome II criteria for identification of upper gastrointestinal disorders in general practice? Scand J Gastroenterol 40 1284–9 Occurrence Handle16334437 Occurrence Handle10.1080/00365520510023576

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

    Hidekazu Suzuki, Toshihiro Nishizawa & Toshifumi Hibi

Authors
  1. Hidekazu Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshihiro Nishizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshifumi Hibi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, H., Nishizawa, T. & Hibi, T. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol 41, 513–523 (2006). https://doi.org/10.1007/s00535-006-1847-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-006-1847-5

Key words

Search

Navigation